Parsi K, Exner T, Connor D E, Ma D D F, Joseph J E
Haematology Research Laboratory, St Vincent's Hospital, Sydney, Australia.
Eur J Vasc Endovasc Surg. 2007 Dec;34(6):731-40. doi: 10.1016/j.ejvs.2007.07.011. Epub 2007 Oct 4.
To investigate the in vitro effects of Sodium Tetradecyl Sulphate (STS) and Polidocanol (POL) on clotting tests, clotting factors, platelets and microparticles.
Platelet rich (PRP) and platelet poor (PPP) plasmas were incubated with varying concentrations of STS and POL. Clotting tests, platelet/plasma turbidity, and microparticle studies were performed. Specimens were mixed with individual factor deficient plasmas and clotting factor activities were studied.
STS at high concentrations (>0.3%) destroyed platelets, microparticles and the clotting factors V, VII and X. It prolonged all clotting tests including prothrombin time (PT), activated partial thromboplastin time (APTT), non-activated partial thromboplastin time (NAPTT), thrombin time (TT), factor Xa clotting time (XACT) and surface activated clotting time (SACT). Higher concentrations of POL were required to achieve some anticoagulant activity. Low sclerosant concentrations shortened XACT and SACT, and induced release of procoagulant platelet derived microparticles. Increased exposure time resulted in increased procoagulant activity. STS at concentrations higher than 0.5% precipitated a complex containing apolipoprotein b and fibrinogen.
Detergent sclerosants affect the clotting mechanism by interfering with clotting factor activities, procoagulant phospholipids and platelet derived microparticles. STS has more anticoagulant activity than POL in high concentrations. Low concentration sclerosants demonstrate procoagulant activity.
研究十四烷基硫酸钠(STS)和聚多卡醇(POL)对凝血试验、凝血因子、血小板及微粒的体外作用。
将富血小板(PRP)血浆和贫血小板(PPP)血浆与不同浓度的STS和POL孵育。进行凝血试验、血小板/血浆浊度及微粒研究。将标本与各因子缺乏血浆混合,研究凝血因子活性。
高浓度(>0.3%)的STS破坏血小板、微粒及凝血因子V、VII和X。它延长所有凝血试验,包括凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、非活化部分凝血活酶时间(NAPTT)、凝血酶时间(TT)、因子Xa凝血时间(XACT)和表面活化凝血时间(SACT)。需要更高浓度的POL才能达到一定的抗凝活性。低硬化剂浓度缩短XACT和SACT,并诱导促凝的血小板衍生微粒释放。暴露时间增加导致促凝活性增加。浓度高于0.5%的STS沉淀出一种含有载脂蛋白b和纤维蛋白原的复合物。
去污剂硬化剂通过干扰凝血因子活性、促凝磷脂和血小板衍生微粒来影响凝血机制。高浓度时,STS的抗凝活性比POL更强。低浓度硬化剂表现出促凝活性。